SCHEMBL4433910

SCHEMBL4433910

Cc1cc2[nH]ccc2cc1N(CC(=O)O)S(=O)(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 14/20 0.48
NFE2L2 Q16236 14/20 0.48
SMN1; SMN2 Q16637 1/20 0.38
GRIN1 Q05586 1/20 0.38
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4439684 0.89 KEAP1 (0.44) KEAP1NFE2L2GRIN1
SCHEMBL4432767 0.88 KEAP1 (0.41) KEAP1NFE2L2TP53
SCHEMBL13390328 0.86 MCOLN3 (0.37) KEAP1NFE2L2SMN1; SMN2TP53
SCHEMBL2850695 0.81 TP53 (0.44) KEAP1NFE2L2SMN1; SMN2TP53
SCHEMBL4430895 0.80 KEAP1 (0.47) KEAP1NFE2L2
SCHEMBL4434295 0.78 KEAP1 (0.43) KEAP1NFE2L2SMN1; SMN2POLBHPGD
SCHEMBL3301093 0.77 ACLY (0.32)
SCHEMBL10357061 0.76 PKM (0.36) KEAP1NFE2L2
SCHEMBL13390314 0.75 PKM (0.35) KEAP1NFE2L2
SCHEMBL4432775 0.74 TP53 (0.41) KEAP1NFE2L2SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed